Metraipolis › archive › dc_2fbcf599a940
Comparative efficacy and safety of Xuebijing injection as adjuvant therapy in sepsis-associated acute kidney injury: a systematic review and meta-analysis — Europe PMC PMID:41194878
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41194878
- DOI
- 10.3389/fphar.2025.1643557
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T04:09:06.290Z
- SHA-256 of the archived text
d3dd7c757dbd0e4ac6def1df2a33c1eef7760e9daf806f078434a545023cdeb3- Stable URL of this page
https://metraipolis.com/documento/dc_2fbcf599a940
How to cite
Comparative efficacy and safety of Xuebijing injection as adjuvant therapy in sepsis-associated acute kidney injury: a systematic review and meta-analysis — Europe PMC PMID:41194878 — Europe PMC (en), https://europepmc.org/article/MED/41194878 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2fbcf599a940 (Metraipolis archive dc_2fbcf599a940, sha256 d3dd7c757dbd0e4ac6def1df2a33c1eef7760e9daf806f078434a545023cdeb3)
BibTeX
@misc{dc2fbcf599a940,
title = {Comparative efficacy and safety of Xuebijing injection as adjuvant therapy in sepsis-associated acute kidney injury: a systematic review and meta-analysis — Europe PMC PMID:41194878},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41194878},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2fbcf599a940; sha256 d3dd7c757dbd0e4ac6def1df2a33c1eef7760e9daf806f078434a545023cdeb3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41194878. Agents can read the archived copy with the MCP tool read_document.